WuXi Biologics has completed the structure of a new microbial commercial manufacturing site in Chengdu and received key equipment shipments, as the contract development and manufacturing company works toward a good-manufacturing-practice, or GMP, release for production by the end of 2026. The site, in Chengdu’s Wenjiang District, broke ground in June 2025 and covers about 95,000 square meters. It is designed to make both drug substance and drug product for biologics derived from microbial fer...